Public Comments

Publish Date
Public Comments
C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement
Public Comments
C4IP Comments RE: Special 301 Review
Public Comments
C4IP Comments RE: WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (PTO-C-2023-0019)
Public Comments
C4IP Comments RE: Joint ITA-NIST-USPTO Collaboration Initiative Regarding Standards (PTO-C-2023-0034)
Public Comments
C4IP Comments RE: 7/31 NIH Tech Transfer Workshop
Public Comments
C4IP Comments RE: PAHPA
Public Comments
C4IP Comments RE: Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings before the Patent Trial and Appeal Board (PTO–P–2020–0022)
Public Comments
C4IP Public Interest Comments RE: ITC Inv. No. 337-TA-1276 – Certain Light-Based Physiological Measurement Devices and Components Thereof
Public Comments
C4IP Written Submission for Inv. No. 332-596
Public Comments
Public Comments on European Commission Draft SEP Regulation
Public Comments
C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program
Public Comments
C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
Resources:

Resources:

C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement,

01/30/2024

Resources:

Resources:

C4IP Comments RE: Special 301 Review,

01/30/2024

Resources:

Resources:

C4IP Comments RE: WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (PTO-C-2023-0019),

01/22/2024

Resources:

Resources:

C4IP Comments RE: Joint ITA-NIST-USPTO Collaboration Initiative Regarding Standards (PTO-C-2023-0034),

11/06/2023

Resources:

Resources:

C4IP Comments RE: 7/31 NIH Tech Transfer Workshop,

07/26/2023

Resources:

Resources:

C4IP Comments RE: PAHPA,

07/10/2023

Resources:

Resources:

C4IP Comments RE: Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings before the Patent Trial and Appeal Board (PTO–P–2020–0022),

06/20/2023

Resources:

Resources:

C4IP Public Interest Comments RE: ITC Inv. No. 337-TA-1276 – Certain Light-Based Physiological Measurement Devices and Components Thereof,

06/05/2023

Resources:

Resources:

C4IP Written Submission for Inv. No. 332-596,

04/26/2023

Resources:

Resources:

Public Comments on European Commission Draft SEP Regulation,

04/19/2023

Resources:

Resources:

C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program,

04/14/2023

Resources:

Resources:

C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Scroll to Top